BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 18990743)

  • 21. A molecular epidemiology case control study on pleural malignant mesothelioma.
    Bolognesi C; Martini F; Tognon M; Filiberti R; Neri M; Perrone E; Landini E; Canessa PA; Ivaldi GP; Betta P; Mutti L; Puntoni R
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1741-6. PubMed ID: 16030111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiologic surveillance for primary prevention of malignant mesothelioma: the Italian experience.
    Nesti M; Marinaccio A; Gennaro V; Gorini G; Mirabelli D; Mensi C; Merler E; Montanaro F; Musti M; Pannelli F; Romanelli A; Tumino R;
    Med Lav; 2005; 96(4):338-46. PubMed ID: 16457430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Etiology, epidemiology, biology. Occupational respiratory cancers].
    Pairon JC; Andujar P; Matrat M; Ameille J
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S18-31. PubMed ID: 18971823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma.
    Bolognesi C; Filiberti R; Neri M; Perrone E; Landini E; Canessa PA; Simonassi C; Cerrano PG; Mutti L; Puntoni R
    Cancer Res; 2002 Oct; 62(19):5418-9. PubMed ID: 12359747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.
    Ugolini D; Neri M; Canessa PA; Casilli C; Catrambone G; Ivaldi GP; Lando C; Marroni P; Paganuzzi M; Parodi B; Visconti P; Puntoni R; Bonassi S
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3013-9. PubMed ID: 18990743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of pleural mesothelioma in Italy.
    Filiberti R; Montanaro F
    Lung Cancer; 2004 Aug; 45 Suppl 1():S25-7. PubMed ID: 15261429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 - an update].
    Porret E; Madelaine J; Galateau-Sallé F; Bergot E; Zalcman G
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S157-64. PubMed ID: 18235409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
    Neri M; Ugolini D; Dianzani I; Gemignani F; Landi S; Cesario A; Magnani C; Mutti L; Puntoni R; Bonassi S
    Mutat Res; 2008; 659(1-2):126-36. PubMed ID: 18420450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the systemic therapy of malignant pleural mesothelioma.
    Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
    Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of a molecular epidemiology approach to human pleural malignant mesothelioma.
    Puntoni R; Filiberti R; Cerrano PG; Neri M; Andreatta R; Bonassi S
    Mutat Res; 2003 Nov; 544(2-3):385-96. PubMed ID: 14644341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular prognostic markers in malignant mesothelioma.
    Kumar P; Kratzke RA
    Lung Cancer; 2005 Jul; 49 Suppl 1():S53-60. PubMed ID: 15950802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence.
    Magnani C
    Med Lav; 2005; 96(4):347-53. PubMed ID: 16457431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesothelioma due to environmental exposure to erionite in Turkey.
    Dikensoy O
    Curr Opin Pulm Med; 2008 Jul; 14(4):322-5. PubMed ID: 18520266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional profiling of mesothelioma using microarrays.
    Gordon GJ
    Lung Cancer; 2005 Jul; 49 Suppl 1():S99-S103. PubMed ID: 15950812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New diagnostic and molecular characteristics of malignant mesothelioma.
    Davidson B
    Ultrastruct Pathol; 2008; 32(6):227-40. PubMed ID: 19117264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues.
    Davies HE; Musk AW; Lee YC
    Curr Opin Pulm Med; 2008 Jul; 14(4):326-30. PubMed ID: 18520267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathways in malignant pleural mesothelioma.
    Whitson BA; Kratzke RA
    Cancer Lett; 2006 Aug; 239(2):183-9. PubMed ID: 16216411
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.